Clinical Trial Update: Intrapleural Docetaxel Administration Using Medical Pleuroscopy in Malignant Effusion With Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating intrapleural docetaxel administration via medical pleuroscopy for malignant pleural effusion in non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Effusion
• Non-small Cell Lung Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Asan Medical Center | Conditions: Pleural Effusion, Malignant, Non-small Cell Carcinoma | Phase 2 | Status: COMPLETED